Top compounds associated with response to POMC


Feature Type Standardized
Nominal ANOVA
mRNA BI-2536 GDSC1000 pan-cancer AAC -0.12 0.02
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.083 0.02
mRNA XMD15-27 GDSC1000 pan-cancer AAC 0.08 0.02
mRNA SMER-3 CTRPv2 pan-cancer AAC 0.086 0.02
mRNA TAE684 GDSC1000 pan-cancer AAC 0.12 0.02
mRNA Obatoclax Mesylate GDSC1000 pan-cancer AAC -0.078 0.02
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.069 0.02
mRNA Bryostatin 1 FIMM pan-cancer AAC -0.36 0.02
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.082 0.02
mRNA Zibotentan GDSC1000 pan-cancer AAC 0.075 0.02
Download CSV